FDA Inspection 1232186 — Zimmer US, Inc
The FDA completed an inspection of Zimmer US, Inc on March 5, 2024 in Southaven, MS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 5, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Southaven, MS (United States)